Asia News
Filter News
Found 30,585 articles
-
Innovative Alzheimer's Treatment from China Concludes Phase 3 Clinical Trials
7/19/2018
Green Valley plans to submit the application for treatment to the China National Drug Administration this Year
-
New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis
7/19/2018
Data to be discussed with global health authorities, including the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)
-
PainReform Gets FDA Approval for Phase III Post-Operative Pain Relief Study
7/18/2018
PainReform Ltd has received FDA approval to conduct two pivotal Phase III clinical trials for post-operative pain relief in soft and hard tissue.
-
Compugen Second Quarter 2018 Conference Call Scheduled for Wednesday, August 1, 2018 at 8:30 AM ET
7/18/2018
Compugen Ltd. announced that the Company will release its second quarter 2018 financial results on Wednesday, August 1, 2018
-
Fresh off its first Pipeline Day last week, Vivek Ramaswamy’s Roivant Sciences is taking aim at breaking into the Chinese market. Roivant has launched another company called Sinovant Sciences.
-
One month after sharing promising interim-Phase I data at the American Society of Clinical Oncology, China-based Ascentage Pharma secured $150 million in Series C financing that will be used to support the development of its pipeline.
-
Therapix Biosciences Announces Positive Data From Recent Pre-clinical Studies for its Drug Candidate THX-160 for Treatment of Pain
7/17/2018
This innovative CB2 receptor agonist was synthesized by Raphael Mechoulam, Ph.D.
-
Groupe Athena, Inc. Releases Year End Financials, Posts Strong Growth
7/17/2018
Groupe Athena, Inc. is very excited to post the results for their fiscal year ending June 30, 2018.
-
Can-Fite Granted Australian and Chinese Patents for Erectile Dysfunction Drug
7/17/2018
Erectile dysfunction market is estimated to reach $3.2 billion by 2022
-
China YCT International Group Files Registration Statement on Form S-1 and Application for NASDAQ Capital Market Listing
7/17/2018
China YCT International Group, Inc. announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed public offering of shares of its common stock
-
Sinovant Sciences and Renexxion Form Partnership to Develop Naronapride in China
7/17/2018
Sinovant Sciences and Renexxion today announced the initiation of a collaboration to pursue the development of naronapride, an investigational gastrointestinal prokinetic, in Greater China.
-
EOS imaging And Fosun Pharmaceutical AG Enter into an Agreement for a Significant Equity Investment
7/17/2018
EOS Imaging, the pioneer of orthopedic medical imaging 2D / 3D, today announced that it entered into a binding agreement with Fosun Pharmaceutical AG, an indirect subsidiary of Shanghai Fosun Pharmaceutical Co., Ltd., related to an equity investment to be made by Fosun Pharmaceutical AG through an issuance of EOS imaging news shares.
-
Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report
7/17/2018
July 17, 2018 12:30 UTC Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report JERUSALEM--( BUSINESS WIRE )-- Today, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) published its annual social impact report, highlighting achievements related to the two pillars that drive the Company’s initiatives: building healthy communities and leading a responsible business. Teva’s 2017 Social Impact Repor
-
Starkey Hearing Foundation Bestows Global Humanitarian Award Upon Bayat Foundation Co-founders Dr. Ehsan Bayat And Mrs. Fatema Laya Bayat
7/16/2018
Afghanistan's Most Renowned Philanthropists Honored For Their Efforts To Bring Hearing Healing And Hope To Afghans
-
NewStem Announces $4 million Seed Investment
7/16/2018
Hebrew University Spinout Focuses on Improving Chemotherapy Success
-
New Study Investigates the Utility of Masimo PVi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery
7/16/2018
Masimo announced today the findings of a recently published study in which researchers at Kocaeli University in Turkey compared the performance of conventional fluid management (CFM) to goal-directed fluid management (GDFM) using Masimo PVi®
-
Peptron Announces Published Data Showing a New Sustained-Release Exendin-4 Formulation Prevents Neurodegeneration in a Parkinson's Disease Model
7/16/2018
Peptron Inc. announced publication of preclinical data from a team of international scientists showing a new sustained-release (SR) exendin-4 formulation reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease.
-
Dr. Reddy's Laboratories announces its intent to appeal court decision in preliminary injunction hearing for Buprenorphine and Naloxone Sublingual Film
7/14/2018
Dr. Reddy’s Laboratories Ltd. announced its intent to appeal the decision made by the U.S. District Court for the District of New Jersey in a preliminary injunction hearing with respect to further sales and commercialization of Dr. Reddy’s Buprenorphine and Naloxone Sublingual Film within the United States.
-
U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
7/13/2018
First and Only Oral Treatment FDA-Approved for Both Non-Metastatic and Metastatic CRPC
-
ROHTO Exhibits Concept Models of Eye-drops for Four Extreme Conditions at Art Gallery in Daikanyama, Tokyo
7/13/2018
SPECIAL EVENT: OUR EYES ARE EXPERIENCING MUCH HARSHER CONDITIONS THAN WE IMAGINE